Dickinson HO

Kitchener HC

Winter-Roach BA

Epithelial ovarian cancer kills about 1700 in the UK each year. Ten to fifteen percent of all cases are diagnosed early when there is still a good chance of cure. The treatment of early stage disease involves surgery to remove disease often followed by chemotherapy. The largest clinical trials of this adjuvant therapy show an overall survival (OS) advantage with adjuvant platinum based chemotherapy but the precise role of this treatment in sub-groups of patients with differing prognoses needs to be defined

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer

Abstract

Similar works

Full text

Available Versions

Newcastle University E-Prints